The global capnography device market size was estimated at USD 426.1 million in 2018 and is anticipated to exhibit a lucrative CAGR of 17.8% in the forthcoming years. Rising incidence of chronic conditions, such as cancer and diabetes, is creating the need for efficient medication delivery, thereby driving the growth. According to the Cancer Research U.K., cancer results in highest number of deaths globally, which has raised the clinical urgency to adopt advanced alternatives, such as capnography device. According to the American Cancer Society, in 2018, almost 1.7 million new cancer cases were registered in U.S. while almost 0.6 million people died due to cancer.
Consequentially, increasing adoption of capnography in anesthesia administration in target applications, such as monitoring patients undergoing procedural sedation, intubated patients during patient transfer in hospitals, and in patient-controlled analgesia, is presumed to boost the product demand over the forecast period. In addition, rising application surgical procedures, such as hypoventilation, endotracheal tube placement, and esophageal intubation is anticipated to further drive the growth.
The aforementioned surgeries are accompanied with better patient outcomes that includes faster detection of respiratory insufficiency, increased acceptance towards due to higher sensitivity and improved patient safety profile. These benefits are expected to increase the usage in near future. Moreover, rising geriatric population and susceptibility of geriatric population towards developing lung disorders are further anticipated to widen the consumer base for capnography procedures over the forecast period.
Moreover, rising geriatric population being more susceptible towards developing lung disorders is anticipated to drive the demand for capnographs. The aforementioned surgeries are accompanied with better patient outcomes that include faster detection of respiratory insufficiency, increased acceptance of this technology due to higher sensitivity, and improved patient safety profile. These benefits are expected to increase the usage of these equipment.
Rising prevalence of respiratory diseases, such as Chronic Obstructive Pulmonary Disease (COPD), pulmonary embolism, and asthma that require intensive respiratory monitoring, is expected to drive the demand. Increasing need for capnography in emergency medicine, prolonged illnesses, and protracted treatments associated with lung diseases in children and adults is expected to drive the market growth. In addition, benefits of capnography such as better optimization of post-operative outcomes, long-term efficacy, improved overall efficiency, and rapid response time are expected to facilitate the growth.
OEM modules held the largest market share in 2018. This is a consequence of OEM modules being a critical component for functioning of capnography devices. Companies that supply integrated OEM modules are growing in number, thereby raising the overall competition and providing lucrative growth opportunities. Presence of extensive distribution channels set up by these companies to market OEM modules is also responsible for the substantial share achieved in this segment.
Furthermore, infrared segment is expected to witness constant growth during the forecast period. Nondispersive Infrared (NDIR) sensors measure gas as a function of the absorbance of Infrared (IR) light, which is the most commonly used technique for real-time CO2 measurement. Moreover, easy availability, portability, and affordability of IR sources are the other benefits that are likely to fuel the demand during the forecast period.
Others include external measurement devices and analyzers, single circuit boards, thermal CO2 sources, filter detectors, connectors, pumps, brushless motors, connector reprogramming firmware, and microchips among others. For instance, EMMA Mainstream Capnometer-Portable Real-time Capnometry-launched by Masimo Corporation is a portable mainstream measurement device used for short-term monitoring of end-tidal CO2 in adults, neonates, and pediatric patients. This segment is predicted to exhibit a steady growth, as availability of these components facilitates continuous respiratory monitoring, allowing clinicians to perform endotracheal intubation and resuscitation, assess the effectiveness and depth of compressions, and recognize air circulation.
The side stream technology segment held the largest market share in 2018, owing to the wide usage of the technology in anesthesia monitoring. Side stream technologically enabled devices offer benefits, such as ease-of-connection, fewer problems in sterilization, and help in monitoring of non-incubated substances with the help of nasal adapters. These factors are responsible for the growth of the segment during the forecast period.
On the other hand, microstream segment is expected to register lucrative growth owing to the rising penetration, attributed to technological advancements in this field. In addition, microstream technology can be used in intubated and non-intubated patients and patients of all age groups. This factor is anticipated to bode well for the segment growth in near future.
The handheld product segment held the largest share in 2018 as a result of the increasing adoption of the product due to the benefits associated with handheld capnographs. These majorly include high portability, facilitation of required oxygen saturation levels in operative procedures, high durability, and low associated costs.
Multi-parameter segment is expected to expand at a lucrative CAGR of 19.1% over the next seven years owing to increasing application of the product in emergency medicines and procedural sedation. Furthermore, advancements in capnographs inclusive of miniaturization of sensors and incorporation of multi-sensors in a single device to enable simultaneous monitoring of multi-gasses have resulted easy and faster sample collection and long-term deployment. The aforementioned factors are anticipated to propel demand for multiparameter capnographs during the forecast period.
This device has wide application in the treatment of procedural sedation in dentistry and is thereby expected to register a lucrative CAGR of above 19.0% over the forecast period. It offers non-invasive, real-time, and continuous measurement by producing capnograms, which help assess the present status of patient's circulatory and metabolic systems. These benefits are expected to increase the adoption of these devices, thereby providing growth to the overall market in near future.
Emergency medicine is anticipated to expand at a steady CAGR during the forecast period. Capnographs are increasingly used in emergency medicine to optimize prehospital ventilation, to handle pediatric emergencies, in ambulatory care centers, and as a prognostic indicator for pulmonary blood flow. Moreover, evolving guidelines and recommendations to include capnography in emergency medicine by the American Heart Association (AHA) and European Resuscitation Council to improve patients’ odds of survival are fueling the demand.
Procedural sedation is anticipated to be the fastest growing segment at CAGR 19.1% during the forecast period. This lucrative growth can be attributed to the rising number of research activities exhibiting benefits of capnography in sedation procedures. In addition, new guidelines pertaining to procedural sedation by organizations such as American Society of Anesthesiologists (ASA) to promote capnography in diagnostic and therapeutic procedures due to associated benefits are expected to drive the market.
The hospital segment held the largest market share in 2018. It is used as a preventive measure to tackle critical events in ICUs. The adoption of capnography procedures is increased in hospitals owing to their enhanced capabilities for calculating patient ventilators measurement, minimally invasive nature, and ease-of-usage. The industry is expected to register upward growth due to the rising incidences of cardiac arrest and thereby creating the need for the effective patient monitoring during the forecast period.
Moreover, organizations such as the American Society of Anesthesiologists and the Uruguayan Society of Anesthesiologists recommended capnography monitoring during anesthetics and procedural sedation. These guidelines support the importance of capnography device in hospital use. In addition, the high influence of the U.S. healthcare system on global healthcare industry has further driven the segment growth.
In 2018, North America held the largest market share in terms of revenue. The rising prevalence of respiratory diseases as a consequence of unhealthy lifestyles and high stress levels are the high impact rendering drivers. Furthermore, the incorporation of new reimbursement models for respiratory and monitoring solution procedures and the stringent regulatory guidelines that are aimed towards medical efficacy, patients’ safety, and clinical efficiency are expected to drive the regional demand in the forthcoming years.
Asia Pacific capnography device market is anticipated to expand at a significant CAGR of 18.5% over the forecast period owing to the expeditiously improving healthcare systems and rising healthcare expenditure and awareness regarding the benefits of this technology.
Some key players are Smiths Medical; Dragerwerk AG & Co. KGaA.; Welch Allyn, Inc.; Masimo Corporation; Philips Healthcare; Medtronic, Inc.; Nonin Medical, Inc.; Nihon Kohden Corporation; CareFusion Corporation; and DiaMedica, Inc.
These players are incorporating strategies such as product launches, geographical expansions, collaborative agreements, and acquisitions, to capture bigger market share. For instance, in 2016, Covidien acquired Oridion for the expansion of capnography segment, which resulted in the sales of USD 100 million in 2013. Moreover, Covidien launched Capnostream 20p, which enabled the company to strengthen its product portfolio.
Base year for estimation
Actual estimates/Historical data
2014 - 2017
2019 - 2026
Revenue in USD Million and CAGR from 2019 to 2026
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, Australia, India, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analysts working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global capnography device market report on the basis of component, product, technology, application, end use, and region:
Component Outlook (Revenue, USD Million, 2014 - 2026)
Product Outlook (Revenue, USD Million, 2014 - 2026)
Technology Outlook (Revenue, USD Million, 2014 - 2026)
Application Outlook (Revenue, USD Million, 2014 - 2026)
End Use Outlook (Revenue, USD Million, 2014 - 2026)
Regional Outlook (Revenue, USD Million, Volume, ‘000 Units, 2014 - 2026)
Middle East & Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.